AviClearRecalls & reported problems
Cutera, Inc. · AviClear Laser System · Class 2
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00816722021700), received between Nov 29, 2025 and Nov 29, 2025 — classified as 1 injury.
The most frequently reported specific device problem is “Improper or Incorrect Procedure or Method” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- Improper or Incorrect Procedure or Method1
Patient problems
- Partial thickness (Second Degree) Burn1
- Scar Tissue1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryNov 29, 2025Improper or Incorrect Procedure or Method; Improper or Incorrect Procedure or Method
THE DEVICE OPERATOR USED THE 7-SPOT ARRAY TO TREAT THE SIDE OF THE NOSE (THE NASAL ALAR CREASE). THE AVICLEAR INSTRUCTIONS FOR USE CLEARLY STATE THAT THIS AREA SHOULD NOT BE TREATED. USING THE DEVICE IN THIS SPOT IS CONSIDERED USER ERROR. THE SHAPE OF THE NASAL CREASE MAKES IT HARD TO COOL THE SKIN PROPERLY BEFORE, DURING, AND AFTER THE LASER PULSE, WHICH INCREASES THE CHANCE OF A BURN IF THE AREA IS TREATED. THE PATIENT WHO RECEIVED THE AVICLEAR TREATMENT ALSO SUBMITTED A VOLUNTARY REPORT TO THE FDA (MW5177086), CHARACTERIZING THE INJURY AS A "THIRD-DEGREE BURN." THE TREATING CLINIC DESCRIBED THE INJURY AS A "SECOND-DEGREE BURN." BURNS AND SCARRING ARE IDENTIFIED IN THE AVICLEAR IFU AS KNOWN POTENTIAL ADVERSE EFFECTS ASSOCIATED WITH THE PROCEDURE. NO CUTERA PERSONNEL WERE PRESENT DURING THE TREATMENT, AND CUTERA WAS NOT INVOLVED IN THE EVALUATION, CLINICAL MANAGEMENT, OR DECISION-MAKING REGARDING PATIENT CARE. ON (B)(6) 2025, THE CLINIC REPORTED THAT THE TREATMENT-RELATED BURN WAS "HEALING NICELY." AT THAT TIME, THE ONLY MEDICAL INTERVENTION PROVIDED WAS TOPICAL "SILVER SULFADIAZINE", WHICH IS STANDARD WOUND CARE FOR PARTIAL-THICKNESS BURNS. ON (B)(6) 2025, THE CLINIC AGAIN CONFIR
Patient problems: Partial thickness (Second Degree) Burn; Scar Tissue
MAUDE report 23675905 ↗
Other Powered Laser Surgical Instrument devices
- Moxy 0010-2400Boston Scientific Corporation · Powered Laser Surgical Instrument4,572 reports
- SOLTIVE TFL-PLSGyrus ACMI, LLC · Powered laser surgical instrument6 recalls450 reports
- Flexiva TracTip M0068403960Boston Scientific Corporation · Powered laser surgical instrument562 reports
- Moses™ AC-10030100Lumenis Ltd. · Powered Laser Surgical Instrument532 reports
- Flexiva M0068403910Boston Scientific Corporation · Powered laser surgical instrument376 reports
- Visualase 9735542Medtronic Navigation, Inc. · Powered laser surgical instrument1 recall2 deaths311 reports
- SOLTIVE TFL-SLSGyrus ACMI, LLC · Powered laser surgical instrument6 recalls33 reports
- NeuroBlate® System 20980Monteris Medical Inc · Powered laser surgical instrument7 deaths296 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.